Achilles Therapeutics plc American Depositary Shares (ACHL)

About Achilles Therapeutics plc American Depositary Shares (ACHL)

Achilles Therapeutics Plc is a biopharmaceutical company engaged in developing transformative precision T-cell therapies to treat multiple types of solid tumors. It focuses on researching, developing and commercializing potentially novel cancer immunotherapies targeting clonal neoantigens. The company was founded by Karl Peggs, Sergio Quezada, Mark Lowdell and Charles Swanton in November 2020 and is headquartered in London, the United Kingdom.

Achilles Therapeutics plc American Depositary Shares News